← FDA Drug Approvals (Drugs@FDA)
TIROFIBAN HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NEXUS · Approved 2023-02-07
Drug application
- FDA Application #
ANDA213947
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TIROFIBAN HYDROCHLORIDE
- Generic name
- TIROFIBAN HYDROCHLORIDE
- Active ingredients
- TIROFIBAN HYDROCHLORIDE
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- NEXUS
- Manufacturer
- Nexus Pharmaceuticals LLC
- First approval
- 2023-02-07
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown